Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Cofactor and Cofactor Mimetics

Peter J. Lenting, PhD

Blood (2019) 134 (Supplement_1): SCI-17.

https://doi.org/10.1182/blood-2019-121059

Published: 2019

Journal Articles

Platelet Desialylation Is a Novel Mechanism of Thrombocytopenia during Mechanical Circulatory Assistance

Hugues Spillemaeker, Annabelle Dupont, PhD PharmD, Alexandre Kauskot, PhD, Antoine Rauch, MD PhD, Flavien Vincent, MD, Delphine Borgel, PharmD, PhD, Alexandre Ung, Mouhamed Moussa, MD, Natacha Rousse, MD, Christophe Nix, MD, Bart Staels, PharmD, PhD, André Vincentelli, MD PhD, Cecile V. Denis, PhD, Peter J Lenting, PhD, Eric van Belle, MD PhD, Sophie Susen, MD PhD

Blood (2017) 130 (Supplement 1): 2330.

https://doi.org/10.1182/blood.V130.Suppl_1.2330.2330

Published: 2017

Journal Articles

Von Willebrand Factor Interaction with FVIII: Development of Long Acting FVIII Therapies

Peter J Lenting, PhD, Vincent Muczynski, PhD, Gabriel Aymé, PhD, Cecile V. Denis, PhD, Olivier D. Christophe, PhD

Blood (2016) 128 (22): SCI-8.

https://doi.org/10.1182/blood.V128.22.SCI-8.SCI-8

Published: 2016

Journal Articles

Mechanisms and Therapeutic Modulation of the Bleeding Tendency in Genetically-Engineered Von Willebrand Disease Type 2B Mice

Fatoumata Tall, MD, Frederic Adam, PhD, Amine Bazaa, PhD, Olivier D. Christophe, PhD, Peter J. Lenting, PhD, Cecile V. Denis, PhD, Valerie Proulle, MD PhD

Blood (2015) 126 (23): 3516.

https://doi.org/10.1182/blood.V126.23.3516.3516

Published: 2015

Journal Articles

Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedures

Antoine Rauch, MD, Eric Van Belle, MD PhD, André Vincentelli, MD PhD, Paulette Legendre, Emmanuelle Jeanpierre, Christopher Hurt, MD, Carlo Banfi, MD, Claudine Caron, Francis Juthier, MD PhD, Ahmed Elkalioubie, MDPhD, Natacha Rousse, MD, Delphine Corseaux, PhD, Christophe Zawadzki, PhD, Giulia Chinetti, PhD, Brigitte Jude, MD PhD, Jenny Goudemand, MD PhD, Bart Staels, Peter J. Lenting, PhD, Sophie Susen, MDPhD

Blood (2014) 124 (21): 474.

https://doi.org/10.1182/blood.V124.21.474.474

Published: 2014

Journal Articles

Determinants of von Willebrand Factor Function

Cécile V. Denis, PhD, Olivier D. Christophe, PhD, Peter J. Lenting, PhD

Blood (2012) 120 (21): SCI-17.

https://doi.org/10.1182/blood.V120.21.SCI-17.SCI-17

Published: 2012

Journal Articles

Active Von Willebrand Factor (VWF) in Plasma of Sickle Cell Patients Is An Indicator of Disease Severity.

Junmei Chen, PhD, William Hobbs, MD, PhD, Jennie Le, Peter J Lenting, PhD, Philip G De Groot, PhD, Jose A. Lopez, MD

Blood (2009) 114 (22): 2552.

https://doi.org/10.1182/blood.V114.22.2552.2552

Published: 2009

Journal Articles

Transition from Non-Platelet-Binding to Platelet-Binding Conformation of Von Willebrand Factor Occurs upon Exocytosis

Evelyn Groot, Rob Fynheer, MD, PhD, Silvie AE Sebastian, Peter J Lenting, PhD, Philip G De Groot, PhD

Blood (2008) 112 (11): 3917.

https://doi.org/10.1182/blood.V112.11.3917.3917

Published: 2008

Journal Articles

Evidence for the Interaction Between VWF Carboxyl-Terminal Domains and ADAMTS13 Domains Distal to Its Spacer Domain

Sara Zanardelli, PhD, Chan Kwo Chion, PhD, Michael Laffan, DM, FRCP, FRCPath, Peter J Lenting, PhD, Evelyn Groot, David Lane

Blood (2008) 112 (11): 3924.

https://doi.org/10.1182/blood.V112.11.3924.3924

Published: 2008

Journal Articles

Active Von Willebrand Factor in Plasma of Sickle Cell Patients Is An Indicator for Severity of Sickle Cell Anemia

Junmei Chen, PhD, William Hobbs, MD, PhD, Jennie Le, Peter J Lenting, PhD, Jose A Lopez, MD

Blood (2008) 112 (11): 5445.

https://doi.org/10.1182/blood.V112.11.5445.5445

Published: 2008

Journal Articles

Beta2-Glycoprotein I Interferes with von Willebrand Factor-Dependent Platelet Adhesion.

Peter J. Lenting, PhD, Janine J. Hulstein, PhD, Bas de Laat, PhD, Ronald H. Derksen, MD,PhD, Rob Fijnheer, MD,PhD, Philip G. de Groot, PhD

Blood (2006) 108 (11): 415.

https://doi.org/10.1182/blood.V108.11.415.415

Published: 2006

Journal Articles

Studies with the Nanobody That Detects the Gain-of-Function of von Willebrand Factor in a Cohort of Patients with Type 2B von Willebrand Disease: Correlation with Platelet Count, VWF Multimers and Molecular Defects.

Augusto B. Federici, MD, Luciano Baronciani, PhD, Maria T. Canciani, PhD, Barbara Moroni, PhD, Carlo Balduini, MD, Pier M. Mannucci, MD, Peter J. Lenting, PhD, Philip G. de Groot, PhD

Blood (2006) 108 (11): 1011.

https://doi.org/10.1182/blood.V108.11.1011.1011

Published: 2006

Journal Articles

O -Linked Glycosylation with Sialylated T-Antigen: A Novel Carbohydrate Determinant of von Willebrand Factor Antigen Levels.

Peter J. Lenting, PhD, Carina J.M. van Schooten, MSc, Ton Lisman, PhD, Marijke van den Berg, MD, PhD, Jeroen C.J. Eikenboom, MD, PhD, Frank W.G. Leebeek, MD, PhD, Jenny Goudemand, MD, PhD, Edith Fressinaud, MD, PhD, Philip G. de Groot, PhD, Cécile V. Denis, PhD

Blood (2006) 108 (11): 178.

https://doi.org/10.1182/blood.V108.11.178.178

Published: 2006

Journal Articles

Interaction of beta2-Glycoprotein I with Members of the Low Density Lipoprotein Receptor Family.

Menno van Lummel, Maarten T.T. Pennings, Ronald H.W.M. Derksen, MD, PhD, Erik Westein, Peter J. Lenting, PhD, Philip G. de Groot, PhD

Blood (2005) 106 (11): 2646.

https://doi.org/10.1182/blood.V106.11.2646.2646

Published: 2005

Journal Articles

Factor VIII Half-Life and Clinical Characteristics of Severe Hemophilia A.

Karin van Dijk, MD, Johanna G. van der Bom, MD, PhD, Eveline P. Mauser-Bunschoten, MD, PhD, Goris Roosendaal, MD, PhD, Peter J. Lenting, PhD, Philip G. de Groot, PhD, H. Marijke van den Berg, MD, PhD

Blood (2004) 104 (11): 3091.

https://doi.org/10.1182/blood.V104.11.3091.3091

Published: 2004

Journal Articles

Identification of Apolipoprotein E Receptor 2′ as the Low-Density Lipoprotein Receptor on Platelets.

Jan-Willem N. Akkerman, PhD, Suzanne J.A. Korporaal, Ingrid A.M. Relou, PhD, Miranda Van Eck, Martineke Bezemer, Gertie Gorter, Theo J.C. Van Berkel, PhD, Johannes Nimf, PhD, Peter J. Lenting, PhD

Blood (2004) 104 (11): 1549.

https://doi.org/10.1182/blood.V104.11.1549.1549

Published: 2004

Journal Articles

Correction of a Murine Model of Von Willebrand Disease by Gene Transfer.

Robert G. Pergolizzi, PhD, Rachel Dragos, BA, Diane Chan, BA, Denisa D. Wagner, PhD, Peter J. Lenting, PhD, Ronald G. Crystal, MD

Blood (2004) 104 (11): 3180.

https://doi.org/10.1182/blood.V104.11.3180.3180

Published: 2004

NARROW

Cofactor and Cofactor Mimetics

Platelet Desialylation Is a Novel Mechanism of Thrombocytopenia during Mechanical Circulatory Assistance

Von Willebrand Factor Interaction with FVIII: Development of Long Acting FVIII Therapies

Mechanisms and Therapeutic Modulation of the Bleeding Tendency in Genetically-Engineered Von Willebrand Disease Type 2B Mice

Von Willebrand Factor As a Biological Sensor of Blood Flow in Percutaneous Cardiac Procedures

Determinants of von Willebrand Factor Function

Active Von Willebrand Factor (VWF) in Plasma of Sickle Cell Patients Is An Indicator of Disease Severity.

Transition from Non-Platelet-Binding to Platelet-Binding Conformation of Von Willebrand Factor Occurs upon Exocytosis

Evidence for the Interaction Between VWF Carboxyl-Terminal Domains and ADAMTS13 Domains Distal to Its Spacer Domain

Active Von Willebrand Factor in Plasma of Sickle Cell Patients Is An Indicator for Severity of Sickle Cell Anemia

Beta2-Glycoprotein I Interferes with von Willebrand Factor-Dependent Platelet Adhesion.

Studies with the Nanobody That Detects the Gain-of-Function of von Willebrand Factor in a Cohort of Patients with Type 2B von Willebrand Disease: Correlation with Platelet Count, VWF Multimers and Molecular Defects.

O -Linked Glycosylation with Sialylated T-Antigen: A Novel Carbohydrate Determinant of von Willebrand Factor Antigen Levels.

Interaction of beta2-Glycoprotein I with Members of the Low Density Lipoprotein Receptor Family.

Factor VIII Half-Life and Clinical Characteristics of Severe Hemophilia A.

Identification of Apolipoprotein E Receptor 2′ as the Low-Density Lipoprotein Receptor on Platelets.

Correction of a Murine Model of Von Willebrand Disease by Gene Transfer.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only